Rosario García-Campelo

Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform Trial

Tina Cascone, Gozde Kar, Jonathan Spicer et al. · Cancer Discovery · 2023 · 101 citations · Full text

Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial

Raquel Laza‐Briviesca, Alberto Cruz‐Bermúdez, Ernest Nadal et al. · Clinical and Translational Medicine · 2021 · 54 citations · Full text

Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy

Marta Casarrubios, Mariano Provencio, Ernest Nadal et al. · Journal for ImmunoTherapy of Cancer · 2022 · 54 citations · Full text

SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022)

Rosario García-Campelo, Ivana Sullivan, Edurne Arriola et al. · Clinical & Translational Oncology · 2023 · 27 citations · Full text

Perioperative durvalumab plus chemotherapy plus new agents for resectable non-small-cell lung cancer: the platform phase 2 NeoCOAST-2 trial

Tina Cascone, Laura Bonanno, Florian Guisier et al. · Nature Medicine · 2025 · 12 citations · Full text